Cesar Santa-Maria

21PUBLICATIONS
129CO-AUTHORS
Cancer geneticsPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jan 28, 2026
TBCRC 048 (Olaparib Expanded) Expansion Cohorts: Phase II Study of Olaparib Monotherapy for Patients With Metastatic Breast Cancer With Germline Mutations in PALB2 or Somatic Mutations in BRCA1 or BRCA2.

Nadine M Tung, Mark E Robson, Tianyu Li

|Nov 10, 2025
Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data.

Frederick M Howard, Peter A Fasching, Cesar A Santa-Maria

|Oct 28, 2024
Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockade.

Theinmozhi Arulraj, Hanwen Wang, Atul Deshpande

|Oct 11, 2024
Poly (ADP-ribose) Polymerase Inhibitor Resistance Driven by Emergence of Polyclonal Mutations With Convergent Evolution: A Molecular Tumor Board Discussion.

Maria Fatteh, Jaime Wehr, Katerina Karaindrou

|Jun 03, 2024
Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockade.

Theinmozhi Arulraj, Hanwen Wang, Atul Deshpande

|Apr 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.

Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson

Pageof 4

Frequent Collaborators

7 joint publications

Antonio C Wolff

4 joint publications

Vered Stearns

4 joint publications

Payal D Shah

3 joint publications

Lisa A Carey